Premier Path Wealth Partners, LLC Amylyx Pharmaceuticals, Inc. Transaction History
Premier Path Wealth Partners, LLC
- $531 Billion
- Q1 2024
A detailed history of Premier Path Wealth Partners, LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Premier Path Wealth Partners, LLC holds 20,265 shares of AMLX stock, worth $40,935. This represents 0.01% of its overall portfolio holdings.
Number of Shares
20,265
Previous 20,265
-0.0%
Holding current value
$40,935
Previous $298 Million
80.71%
% of portfolio
0.01%
Previous 0.07%
Shares
1 transactions
Others Institutions Holding AMLX
# of Institutions
184Shares Held
50.4MCall Options Held
5.82MPut Options Held
2.06M-
Vanguard Group Inc Valley Forge, PA5.35MShares$10.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.47MShares$9.04 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.94MShares$5.95 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.47MShares$4.99 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.07MShares$4.18 Million0.0% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $118M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...